Agf Investments LLC Vertex Pharmaceuticals Inc Transaction History

Agf Investments LLC

$1.09 Billion
Q3 2022

A detailed history of Agf Investments LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Agf Investments LLC holds 6,072 shares of VRTX stock, worth $2.74 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

6,072

Previous 3,528 72.11%

Holding current value

$2.74 Million

Previous $994,000 76.86%

% of portfolio

0.16%

Previous 0.09%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $696,623 - $777,268	2,544 Added 72.11%	6,072 $1.76 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $10,808 - $13,457	-46 Reduced 1.29%	3,528 $994,000
Q1 2022 May 10, 2022	SELL	$221.42 - $260.97 $717,622 - $845,803	-3,241 Reduced 47.56%	3,574 $933,000
Q4 2021 Feb 01, 2022	BUY	$177.01 - $223.45 $135,589 - $171,162	766 Added 12.66%	6,815 $1.5 Million
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $169,781 - $189,998	936 Added 18.31%	6,049 $1.1 Million
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $24,561 - $28,964	131 Added 2.63%	5,113 $1.03 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $350,484 - $408,537	-1,693 Reduced 25.36%	4,982 $1.07 Million
Q4 2020 Feb 08, 2021	SELL	$207.01 - $276.09 $82,389 - $109,883	-398 Reduced 5.63%	6,675 $1.58 Million
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $538,654 - $638,631	-2,107 Reduced 22.95%	7,073 $1.93 Million
Q2 2020 Aug 11, 2020	BUY	$225.48 - $295.8 $826,158 - $1.08 Million	3,664 Added 66.42%	9,180 $2.67 Million
Q1 2020 May 08, 2020	SELL	$199.77 - $247.81 $303,250 - $376,175	-1,518 Reduced 21.58%	5,516 $1.31 Million
Q4 2019 Feb 12, 2020	SELL	$166.71 - $223.91 $395,602 - $531,338	-2,373 Reduced 25.23%	7,034 $1.54 Million
Q3 2019 Nov 12, 2019	SELL	$166.23 - $187.09 $21,942 - $24,695	-132 Reduced 1.38%	9,407 $1.59 Million
Q2 2019 Jul 30, 2019	BUY	$164.61 - $190.37 $948,318 - $1.1 Million	5,761 Added 152.49%	9,539 $1.75 Million
Q1 2019 May 13, 2019	BUY	$163.73 - $194.7 $491,353 - $584,294	3,001 Added 386.23%	3,778 $695,000
Q4 2018 Feb 08, 2019	BUY	$151.91 - $192.21 $5,316 - $6,727	35 Added 4.72%	777 $129,000
Q3 2018 Nov 07, 2018	SELL	$167.73 - $192.74 $148,441 - $170,574	-885 Reduced 54.39%	742 $143,000
Q2 2018 Aug 13, 2018	BUY	$145.72 - $169.96 $237,086 - $276,524	1,627 New	1,627 $277,000
Q1 2018 May 04, 2018	SELL	$151.6 - $177.13 $20,617 - $24,089	-136 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$137.28 - $155.55 $9,884 - $11,199	72 Added 112.5%	136 $21,000
Q3 2017 Nov 09, 2017	BUY	$148.13 - $162.24 $9,480 - $10,383	64	64 $10,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments LLC with notifications on news.

Account

Agf Investments LLC Vertex Pharmaceuticals Inc Transaction History